Agile Therapeutics
AGRX
$0.36
Share price
-0.82%
Change (1 day)
-90.30%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Total assets
Total assets on the balance sheet as of March 2024 : $12.61 M
According to Agile Therapeutics 's latest financial reports the company's total assets are $12.61 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Agile Therapeutics - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $14.24 M | -63.79% |
| 2021-12-31 | $39.33 M | -46.16% |
| 2020-12-31 | $73.06 M | 47.48% |
| 2019-12-31 | $49.54 M | 121.24% |
| 2018-12-31 | $22.39 M | -55.74% |
| 2017-12-31 | $50.59 M | -20.78% |
| 2016-12-31 | $63.86 M | 26.67% |
| 2015-12-31 | $50.42 M | -8.03% |
| 2014-12-31 | $54.82 M | 280.6% |
| 2013-12-31 | $14.4 M | -47.65% |
| 2012-12-31 | $27.51 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 1,363,627.20% | 🇺🇸 USA |
 Pfizer PFE | $221.09 B | 1,753,230.69% | 🇺🇸 USA |
 Merck MRK | $105.84 B | 839,305.23% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $42.08 M | 233.77% | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | N/A | 🇺🇸 USA |